Coelho Philip H's Form 4 filing
Catalyst Pharmaceuticals, Inc. (CPRX) · filed Aug 26, 2021
- Accession no.
- 0001161697-21-000408
- Filed
- Aug 26, 2021
- Trade date
- Aug 24-26, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions and 3 derivative transactions. Open-market sales total $157.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Coelho Philip HCIK 0001109775 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 24, 2021 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +16,667 | $3.12 | +$52,001.04 | 233,427 | Direct | |
| Aug 24, 2021 | Common stock, par value $0.001 per share | SSaleDisposed | −9,494 | $5.58F1 | −$52,976.52 | 223,933 | Direct | |
| Aug 25, 2021 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +16,667 | $3.12 | +$52,001.04 | 240,600 | Direct | |
| Aug 25, 2021 | Common stock, par value $0.001 per share | SSaleDisposed | −9,498 | $5.56F1 | −$52,808.88 | 231,102 | Direct | |
| Aug 26, 2021 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +16,666 | $3.12 | +$51,997.92 | 247,768 | Direct | |
| Aug 26, 2021 | Common stock, par value $0.001 per share | SSaleDisposed | −9,044 | $5.45F1 | −$49,289.8 | 238,724 | Direct | |
| Aug 26, 2021 | Common stock, par value $0.001 per share | SSaleDisposed | −504 | $5.46F1 | −$2,751.84 | 238,220 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 24, 2021 | Common Stock | MOption exerciseDisposed | −16,667 | $0.00 | $0 | 339,500 | Direct | |
| Aug 25, 2021 | Common Stock | MOption exerciseDisposed | −16,667 | $0.00 | $0 | 322,833 | Direct | |
| Aug 26, 2021 | Common Stock | MOption exerciseDisposed | −16,666 | $0.00 | $0 | 306,167 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Shares were sold to cover exercise price of options.
Referenced by the price of 4 transactions in Table I.